Title:
αアドレナリン受容体拮抗薬と抗ムスカリン薬の併用
Document Type and Number:
Japanese Patent JP2012507484
Kind Code:
A
Abstract:
The combined use of (R)-5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide (tamsulosin), or its pharmaceutically acceptable salt, and (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3R)-quinuclidin-3-yl ester (solifenacin), or its pharmaceutically acceptable salt, for the preparation of a medicament for the improvement of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTSBPH) with a substantial storage component is provided.
More Like This:
| JP2015166316 | INDOLE DERIVATIVE OR SALT THEREOF |
| WO/2001/085693 | N-ACYLTETRAHYDROISOQUINOLINE DERIVATIVES |
| JP2023508955 | Novel compounds suitable for the treatment of dyslipidemia |
Inventors:
Fan Charles Dorp Carlin Juliete
Bossman Brigitte Johanna Funny
Krafell Monique Maria Arida
Garcia Hernandez Alberto
Drohendijk Tennis Edwin
Bossman Brigitte Johanna Funny
Krafell Monique Maria Arida
Garcia Hernandez Alberto
Drohendijk Tennis Edwin
Application Number:
JP2011533629A
Publication Date:
March 29, 2012
Filing Date:
November 04, 2009
Export Citation:
Assignee:
Astellas Ireland Company Limited
International Classes:
A61K31/4725; A61K31/18; A61P13/08; A61P13/10; A61P43/00
Foreign References:
| WO2003103659A1 | 2003-12-18 |
Other References:
JPN6014010142; ＩＣＳ ２００８ ３８ＴＨ ＡＮＮＵＡＬ ＭＥＥＴＩＮＧ ＳＣＩＥＮＴＩＦＩＣ ＰＲＯＧＲＡＭＭＥ ２０ Ｏｃｔ ２００８， ２８７
Attorney, Agent or Firm:
Koichi Tsujii
Sadao Kumakura
Atsushi Hakoda
Kenji Asai
Koji Hirayama
Kazuo Yamazaki
Satsuki Ichikawa
Sadao Kumakura
Atsushi Hakoda
Kenji Asai
Koji Hirayama
Kazuo Yamazaki
Satsuki Ichikawa